organization · Reporting owner
ALYESKA INVESTMENTS, LLC
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| E2open Parent Holdings, Inc.PCPL · Entity 76849 | 10% owner | December 16, 2020 | December 17, 2020 |
| MedAvail Holdings, Inc.MDVL · Entity 94590 | 10% owner | April 04, 2022 | May 23, 2022 |
| SOC Telemed, Inc.HCCO · Entity 128175 | 10% owner | October 30, 2020 | November 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
E2open Parent Holdings, Inc.
Report date December 16, 2020 · Filed December 17, 2020
Jointly reported with Alyeska Investment Group, L.P., Alyeska Master Fund, L.P., ALYESKA FUND GP, LLC, ALYESKA INVESTMENT GROUP, LLC, PAREKH ANAND
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | Direct | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Class A Ordinary SharesSEC Table I · non-derivative | Direct | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectFootnotes | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectFootnotes | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectFootnotes | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectFootnotes | 4,668,639 |
Reported balance
After 2020-12-16 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2020-12-16 · Purchase · Acquired 34,800 · Balance 4,668,639 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
Filing footnotes · ownership attribution and instrument terms
F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 4,668,639 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund, and does not hold a pecuniary interest in such Shares.
F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund.
F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4: The price reported in Column 4 is a weighted average price. These Shares were purchased by the Fund in multiple transactions at prices ranging from $10.25 to $10.30, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this footnote 4.
F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act.
MedAvail Holdings, Inc.
Report date April 04, 2022 · Filed May 23, 2022
Jointly reported with Alyeska Investment Group, L.P., Alyeska Master Fund, L.P., ALYESKA FUND GP, LLC, ALYESKA INVESTMENT GROUP, LLC, PAREKH ANAND
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | Direct | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 7,539,411 |
Reported balance
Holding disclosure · report date 2022-04-04 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 7,539,411 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | IndirectFootnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | IndirectFootnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | IndirectFootnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2027-04-04 | IndirectFootnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2022-04-04 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance Not disclosed F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund. F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
Filing footnotes · ownership attribution and instrument terms
F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants.
F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund.
F3: The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4: The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act.
SOC Telemed, Inc.
Report date October 30, 2020 · Filed November 03, 2020
Jointly reported with Alyeska Investment Group, L.P., Alyeska Master Fund, L.P., Alyeska Master Fund 3, L.P., ALYESKA FUND GP, LLC, ALYESKA FUND 3 GP, LLC, ALYESKA INVESTMENT GROUP, LLC, PAREKH ANAND
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 3,200,000 |
Reported balance
After 2020-10-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-10-30 · Purchase · Acquired 25,000 · Balance 3,200,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | Direct | 3,174,601 |
Reported balance
After 2020-10-30 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-10-30 · Purchase · Acquired 24,801 · Balance 3,174,601 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | Direct | 25,399 |
Reported balance
After 2020-10-30 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-10-30 · Purchase · Acquired 199 · Balance 25,399 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | IndirectFootnotes | 3,174,601 |
Reported balance
After 2020-10-30 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-10-30 · Purchase · Acquired 24,801 · Balance 3,174,601 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | IndirectFootnotes | 25,399 |
Reported balance
After 2020-10-30 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-10-30 · Purchase · Acquired 199 · Balance 25,399 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | IndirectFootnotes | 3,200,000 |
Reported balance
After 2020-10-30 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2020-10-30 · Purchase · Acquired 25,000 · Balance 3,200,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | IndirectFootnotes | 3,200,000 |
Reported balance
After 2020-10-30 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2020-10-30 · Purchase · Acquired 25,000 · Balance 3,200,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
| Class A Common StockSEC Table I · non-derivative | IndirectFootnotes | 3,200,000 |
Reported balance
After 2020-10-30 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2020-10-30 · Purchase · Acquired 25,000 · Balance 3,200,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. |
Filing footnotes · ownership attribution and instrument terms
F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares.
F2: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds.
F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively.
F5: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FrontView REIT, Inc.
Report date October 03, 2024 · Filed October 08, 2024
Jointly reported with Alyeska Investment Group, L.P., Alyeska Master Fund, L.P., ALYESKA FUND GP, LLC, ALYESKA INVESTMENT GROUP, LLC, PAREKH ANAND
Section 16 reporting ended · disclosed 2024-10-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | Direct | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | Direct | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
| Common StockSEC Table I · non-derivative | Direct | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,635,135 |
Reported balance
After 2024-10-03 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-10-03 · Purchase · Acquired 135,135 · Balance 1,635,135 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,467,012 |
Reported balance
After 2024-10-08 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2024-10-08 · Sale · Disposed 168,123 · Balance 1,467,012 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,467,012 shares of Common Stock, par value $0.01 per share ("Shares"), of FrontView REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares.
F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund.
F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act.
F5: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.87 to $19.25, inclusive. The Investment Manager undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4.
F6: The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $18.30 to $18.61, inclusive.
Strawberry Fields REIT, Inc.
Report date December 05, 2024 · Filed December 06, 2024
Jointly reported with Alyeska Investment Group, L.P., Alyeska Master Fund, L.P., ALYESKA FUND GP, LLC, ALYESKA INVESTMENT GROUP, LLC, PAREKH ANAND
Section 16 reporting ended · disclosed 2024-12-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | Direct | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | Direct | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | Direct | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,099,600 |
Reported balance
After 2024-12-05 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-12-05 · Sale · Disposed 400 · Balance 1,099,600 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
| Common StockSEC Table I · non-derivative | IndirectFootnotes | 1,050,000 |
Reported balance
After 2024-12-05 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2024-12-05 · Sale · Disposed 49,600 · Balance 1,050,000 F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares. F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund. F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. |
Filing footnotes · ownership attribution and instrument terms
F1: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 1,050,000 shares of Common Stock, par value $0.0001 per share ("Shares"), of Strawberry Fields REIT, Inc. (the "Issuer"). The Investment Manager receives an asset-based fee relating to the Shares directly held by the Fund and does not hold a pecuniary interest in such Shares.
F2: (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Fund.
F3: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2020 Filed Nov 3, 2020 01:39 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 24,801 | $9.04 | $224,201.04 |
DisclosureSEC source: 0000899243-20-030132 · doc4.xml · nonDerivative · entry 4 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,100,196 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 01:39 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 199 | $9.04 | $1,798.96 |
DisclosureSEC source: 0000899243-20-030132 · doc4.xml · nonDerivative · entry 3 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,804 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 01:39 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 24,801 | $9.04 | $224,201.04 |
DisclosureSEC source: 0000899243-20-030132 · doc4.xml · nonDerivative · entry 2 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100,196 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 01:39 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 25,000 | $9.04 | $226,000.00 |
DisclosureSEC source: 0000899243-20-030132 · doc4.xml · nonDerivative · entry 1 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,174,601 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 25,399 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 30, 2020, Fund 1 purchased 24,801, 24,802, 24,802 and 24,801 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively, and Fund 3 purchased 199, 198, 198 and 199 Shares for $9.04, $9.05, $9.09 and $9.15 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. The Form 4 for certain additional transactions is being filed separately and simultaneously with this Form 4 due to the limitation of 30 rows in Table I. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 5,000 | $10.19 | $50,950.00 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 8 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 4,279,001 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 5,000 | $10.19 | $50,950.00 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 7 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 4,279,001 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 5,000 | $10.19 | $50,950.00 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 6 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 4,279,001 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 40 | $10.19 | $407.60 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 5 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 33,960 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 4,960 | $10.19 | $50,542.40 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 4 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 4,245,041 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 40 | $10.19 | $407.60 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 3 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,960 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 4,960 | $10.19 | $50,542.40 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 2 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,245,041 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:05 UTC | E2open Parent Holdings, Inc. PCPL · Entity 76849 | SaleClass A Ordinary Shares | 5,000 | $10.19 | $50,950.00 |
DisclosureSEC source: 0000899243-20-028301 · doc4.xml · nonDerivative · entry 1 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,279,001 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 4,245,041 shares of Class A Ordinary Shares, par value $0.0001 per share ("Shares"), of CC Neuberger Principal Holdings I. Fund 3 is the direct owner of 33,960 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 14, 2020, Fund 1 sold 4,960 Shares for $10.19 per Share, and Fund 3 sold 40 Shares for $10.19 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,787 | $10.01 | $138,007.87 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 16 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,100,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,787 | $10.01 | $138,007.87 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 15 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,100,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,787 | $10.01 | $138,007.87 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 14 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,100,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 109 | $10.01 | $1,091.09 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 13 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 24,605 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,678 | $10.01 | $136,916.78 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 12 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,075,395 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 109 | $10.01 | $1,091.09 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 11 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,605 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,678 | $10.01 | $136,916.78 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 10 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,075,395 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 13,787 | $10.01 | $138,007.87 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 9 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 86,213 | $10.00 | $862,130.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 8 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,086,213 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 86,213 | $10.00 | $862,130.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 7 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,086,213 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 86,213 | $10.00 | $862,130.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 6 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,086,213 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 684 | $10.00 | $6,840.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 5 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 24,496 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 85,529 | $10.00 | $855,290.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 4 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,061,717 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 684 | $10.00 | $6,840.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 3 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,496 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 85,529 | $10.00 | $855,290.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 2 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,061,717 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 20:05 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 86,213 | $10.00 | $862,130.00 |
DisclosureSEC source: 0000899243-20-028168 · doc4.xml · nonDerivative · entry 1 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086,213 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 3,075,395 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 24,605 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 12, 2020, Fund 1 purchased 85,529 Shares for $10.00 per Share, and Fund 3 purchased 684 Shares for $10.00 per Share. On October 13, 2020, Fund 1 purchased 13,678 Shares for $10.01 per Share, and Fund 3 purchased 109 Shares for $10.01 per Share. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,842 | $10.06 | $622,130.52 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 24 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,000,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,842 | $10.06 | $622,130.52 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 23 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,000,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,842 | $10.06 | $622,130.52 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 22 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 3,000,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 491 | $10.06 | $4,939.46 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 21 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 23,812 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,351 | $10.06 | $617,191.06 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 20 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,976,188 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 491 | $10.06 | $4,939.46 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 19 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,812 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,351 | $10.06 | $617,191.06 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 18 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,976,188 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 61,842 | $10.06 | $622,130.52 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 17 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 169,603 | $10.05 | $1,704,510.15 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 16 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,938,158 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 169,603 | $10.05 | $1,704,510.15 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 15 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,938,158 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 169,603 | $10.05 | $1,704,510.15 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 14 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,938,158 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 1,345 | $10.05 | $13,517.25 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 13 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 23,321 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 168,258 | $10.05 | $1,690,992.90 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 12 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,914,837 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 1,345 | $10.05 | $13,517.25 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 11 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,321 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 168,258 | $10.05 | $1,690,992.90 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 10 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,914,837 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 169,603 | $10.05 | $1,704,510.15 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 9 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,938,158 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 98,381 | $10.04 | $987,745.24 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 8 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,768,555 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 98,381 | $10.04 | $987,745.24 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 7 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,768,555 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 98,381 | $10.04 | $987,745.24 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 6 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,768,555 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 782 | $10.04 | $7,851.28 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 5 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 21,976 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 97,599 | $10.04 | $979,893.96 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 4 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,746,579 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. F2 · ownership.nature: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. Read SEC document |
| October 06, 2020 Filed Oct 13, 2020 20:59 UTC | SOC Telemed, Inc. HCCO · Entity 128175 | PurchaseClass A Common Stock | 782 | $10.04 | $7,851.28 |
DisclosureSEC source: 0000899243-20-028016 · doc4.xml · nonDerivative · entry 3 Alyeska Investment Group, L.P. · CIK 0001453072 · 10% owner Alyeska Master Fund, L.P. · CIK 0001456506 · 10% owner Alyeska Master Fund 3, L.P. · CIK 0001775953 · 10% owner ALYESKA FUND GP, LLC · CIK 0001822287 · 10% owner ALYESKA FUND 3 GP, LLC · CIK 0001822509 · 10% owner ALYESKA INVESTMENT GROUP, LLC · CIK 0001822286 · 10% owner ALYESKA INVESTMENTS, LLC · CIK 0001822281 · 10% owner PAREKH ANAND · CIK 0001822280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,976 F1 · security: Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. F2 · security: (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. F3 · security: The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. F4 · security: On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. F5 · security: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.